secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001213900-24-061355
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive receives Nasdaq deficiency notices for bid price and market value
---------------------------------------------------------------------------

- On July 9, 2024, Nasdaq notified Unicycive that stock bid price closed below $1.00 for 30 consecutive days, violating Listing Rule 5550(a)(2).
- On July 11, 2024, Nasdaq notified that Market Value of Listed Securities was below $35M for 30 consecutive days, violating Rule 5550(b)(2).
- Company has 180 calendar days (until Jan 6/7, 2025) to regain compliance for each deficiency by meeting thresholds for 10 consecutive business days.
- If non-compliant after grace period, Nasdaq may delist; company can appeal. No assurance of maintaining listing.
- Stock continues trading on Nasdaq Capital Market under UNCY; company monitoring and evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024061355/0001213900-24-061355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024061355/ea0209297-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-061355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer